Susquehanna International Group
ROSG

Susquehanna International Group’s Rosetta Genomics Ltd. ROSG Stock Holding History

Susquehanna International Group’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,808
Closed -$37K – 9880
2016
Q1 		$37K Sell
2,808
-225
-7% -$2.87K ﹤0.01% 8725
2015
Q4 		$45K Buy
+3,033
New +$65.4K ﹤0.01% 9121
2014
Q3 		– Sell
-3,167
Closed -$165K – 10337
2014
Q2 		$165K Sell
3,167
-575
-15% -$28.5K ﹤0.01% 9196
2014
Q1 		$224K Buy
+3,742
New +$193K ﹤0.01% 8071
2013
Q4 		– Sell
-1,667
Closed -$64K – 9581
2013
Q3 		$64K Sell
1,667
-375
-18% -$15.2K ﹤0.01% 8187
2013
Q2 		$83K Buy
+2,042
New +$90.7K ﹤0.01% 7856

Other funds holding ROSG

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

Susquehanna International Group's ROSG Position: Q1 2018 in Review

Susquehanna International Group sold out of Rosetta Genomics Ltd. (ROSG) in Q1 2018, closing a stake of 36,171 shares — an estimated $20K sold.

Susquehanna International Group first reported a position in ROSG in Q1 2014 and held it in 7 quarters. The position peaked at $247K in Q2 2014. 8 funds tracked by Wall St. Rank hold ROSG as of Q1 2018.

  • Susquehanna International Group reported no remaining Rosetta Genomics Ltd. position as of Q1 2018 after selling out during the quarter.
  • Susquehanna International Group sold 36,171 Rosetta Genomics Ltd. shares in Q1 2018, an estimated $20K.
  • Susquehanna International Group first reported a position in Rosetta Genomics Ltd. in Q1 2014 and held it in 7 quarters.
  • Susquehanna International Group's Rosetta Genomics Ltd. position peaked at $247K in Q2 2014.
  • 8 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.